Downregulation of c-SRC kinase CSK promotes castration resistant prostate cancer and pinpoints a novel disease subclass

SRC kinase is activated in castration resistant prostate cancer (CRPC), phosphorylates the androgen receptor (AR), and causes its ligand-independent activation as a transcription factor. However, activating SRC mutations are exceedingly rare in human tumors, and mechanisms of ectopic SRC activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Chih-Cheng, Fazli, Ladan, Loguercio, Salvatore, Zharkikh, Irina, Aza-Blanc, Pedro, Gleave, Martin E., Wolf, Dieter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673146/
https://www.ncbi.nlm.nih.gov/pubmed/26091350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673146/
https://www.ncbi.nlm.nih.gov/pubmed/26091350

Ejemplares similares